TransMedics Group Inc (NASDAQ:TMDX) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 ...

If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...

Global Retirement Partners LLC increased its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by ...

TransMedics Group (NASDAQ:TMDX – Get Free Report) will likely be announcing its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...

Beyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...

NEW YORK, Feb. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The ...

Learn more about whether Haemonetics Corporation or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.